Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration
<p>Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm and myelodysplastic syndrome [1]. According to the 2016 WHO classification of hematologic malignancies it is categorized as My...
Đã lưu trong:
| Những tác giả chính: | , |
|---|---|
| Định dạng: | Sách |
| Được phát hành: |
Archives of Hematology Case Reports and Reviews - Peertechz Publications,
2020-11-07.
|
| Những chủ đề: | |
| Truy cập trực tuyến: | Connect to this object online. |
| Các nhãn: |
Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| Tóm tắt: | <p>Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm and myelodysplastic syndrome [1]. According to the 2016 WHO classification of hematologic malignancies it is categorized as MyeloDysplastic /Myeloproliferative Neoplasm [2].</p> |
|---|---|
| DOI: | 10.17352/ahcrr.000026 |